S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
NYSE:AVTR

Avantor (AVTR) Stock Price, News & Analysis

$24.10
-0.20 (-0.82%)
(As of 04/19/2024 ET)
Today's Range
$24.08
$24.35
50-Day Range
$22.13
$26.07
52-Week Range
$16.63
$26.16
Volume
4.71 million shs
Average Volume
3.85 million shs
Market Capitalization
$16.35 billion
P/E Ratio
50.21
Dividend Yield
N/A
Price Target
$26.71

Avantor MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
10.8% Upside
$26.71 Price Target
Short Interest
Bearish
4.32% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-2.27
Upright™ Environmental Score
News Sentiment
0.71mentions of Avantor in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$151,911 Sold Last Quarter
Proj. Earnings Growth
22.77%
From $1.01 to $1.24 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.67 out of 5 stars

Medical Sector

65th out of 909 stocks

Analytical Instruments Industry

2nd out of 26 stocks

AVTR stock logo

About Avantor Stock (NYSE:AVTR)

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

AVTR Stock Price History

AVTR Stock News Headlines

Avantor (NYSE:AVTR) PT Raised to $25.00
Double your money before lunch?
Unlike bacterial infections, viral infections can be difficult to treat with medicine. Usually, if you've got a virus, your doctor's best advice is to simply rest and allow your immune system to fight back. Antiviral medications prevent viruses from reproducing, but they can't actually stop the virus. However, scientists may have just found a new way to fight back.
Avantor (AVTR) Scheduled to Post Quarterly Earnings on Friday
Bank of America Securities Keeps Their Buy Rating on Avantor (AVTR)
Avantor (NYSE:AVTR) Price Target Raised to $30.00
Double your money before lunch?
Unlike bacterial infections, viral infections can be difficult to treat with medicine. Usually, if you've got a virus, your doctor's best advice is to simply rest and allow your immune system to fight back. Antiviral medications prevent viruses from reproducing, but they can't actually stop the virus. However, scientists may have just found a new way to fight back.
Avantor Sees Unusually Large Options Volume (NYSE:AVTR)
RBC Capital Keeps Their Buy Rating on Avantor (AVTR)
9 Analysts Assess Avantor: What You Need To Know
AVTR Mar 2024 27.500 put
AVTR Mar 2024 26.000 call
AVTR Mar 2024 24.500 put
AVTR Mar 2024 25.000 call
AVTR Mar 2024 29.000 put
See More Headlines
Receive AVTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avantor and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/14/2024
Today
4/21/2024
Next Earnings (Confirmed)
4/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Fax
N/A
Employees
14,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$26.71
High Stock Price Target
$30.00
Low Stock Price Target
$22.00
Potential Upside/Downside
+10.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
16 Analysts

Profitability

Net Income
$321.10 million
Pretax Margin
5.89%

Debt

Sales & Book Value

Annual Sales
$6.97 billion
Cash Flow
$1.68 per share
Book Value
$7.77 per share

Miscellaneous

Free Float
668,107,000
Market Cap
$16.35 billion
Optionable
Optionable
Beta
1.37
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

AVTR Stock Analysis - Frequently Asked Questions

Should I buy or sell Avantor stock right now?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last year. There are currently 4 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AVTR shares.
View AVTR analyst ratings
or view top-rated stocks.

What is Avantor's stock price target for 2024?

16 brokers have issued 12-month target prices for Avantor's stock. Their AVTR share price targets range from $22.00 to $30.00. On average, they predict the company's stock price to reach $26.71 in the next twelve months. This suggests a possible upside of 10.8% from the stock's current price.
View analysts price targets for AVTR
or view top-rated stocks among Wall Street analysts.

How have AVTR shares performed in 2024?

Avantor's stock was trading at $22.83 at the beginning of the year. Since then, AVTR shares have increased by 5.6% and is now trading at $24.10.
View the best growth stocks for 2024 here
.

Are investors shorting Avantor?

Avantor saw a increase in short interest in March. As of March 31st, there was short interest totaling 29,290,000 shares, an increase of 6.6% from the March 15th total of 27,470,000 shares. Based on an average daily volume of 5,900,000 shares, the short-interest ratio is currently 5.0 days.
View Avantor's Short Interest
.

When is Avantor's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, April 26th 2024.
View our AVTR earnings forecast
.

How can I listen to Avantor's earnings call?

Avantor will be holding an earnings conference call on Friday, April 26th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Avantor's earnings last quarter?

Avantor, Inc. (NYSE:AVTR) issued its earnings results on Wednesday, February, 14th. The company reported $0.25 earnings per share for the quarter, beating analysts' consensus estimates of $0.22 by $0.03. The company earned $1.72 billion during the quarter, compared to analysts' expectations of $1.70 billion. Avantor had a trailing twelve-month return on equity of 14.11% and a net margin of 4.61%. Avantor's quarterly revenue was down 4.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.32 earnings per share.

What guidance has Avantor issued on next quarter's earnings?

Avantor issued an update on its FY 2024 earnings guidance on Wednesday, February, 14th. The company provided earnings per share guidance of 0.960-1.040 for the period, compared to the consensus estimate of 1.060. The company issued revenue guidance of -.

What other stocks do shareholders of Avantor own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avantor investors own include Johnson & Johnson (JNJ), NVIDIA (NVDA), Procter & Gamble (PG), RTX (RTX), Alibaba Group (BABA), CVS Health (CVS), Home Depot (HD), Pfizer (PFE) and QUALCOMM (QCOM).

When did Avantor IPO?

Avantor (AVTR) raised $3 billion in an IPO on Friday, May 17th 2019. The company issued 154,000,000 shares at a price of $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies served as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Who are Avantor's major shareholders?

Avantor's stock is owned by many different retail and institutional investors. Top institutional investors include Artemis Investment Management LLP (1.34%), Sumitomo Mitsui Trust Holdings Inc. (0.24%), Perpetual Ltd (0.19%), Vaughan Nelson Investment Management L.P. (0.18%), Dudley & Shanley Inc. (0.16%) and Allspring Global Investments Holdings LLC (0.13%). Insiders that own company stock include Christophe Couturier, David D Petratis, Devashish Ohri, Frederic Vanderhaegen, Gerard Brophy, James Bramwell, Jo Natauri, Justin Miller, Michael Stubblefield, Rajiv Gupta, Steven W Eck and Thomas A Szlosek.
View institutional ownership trends
.

How do I buy shares of Avantor?

Shares of AVTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:AVTR) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners